APPLIED THERAPEUTICS INC. - COMMON STOCK
8.9200
13-November-24 16:45:00
15 minutes delayed
Stocks
-0.9800
-9.90%
Today's range
8.9100 - 10.0500
ISIN
N/A
Source
NASDAQ
-
Applied Therapeutics Reports Third Quarter 2024 Financial Results
07 Nov 2024 07:00:01 By Nasdaq GlobeNewswire
-
18 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics to Participate in Upcoming Investor Conferences
04 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics Reports Second Quarter 2024 Financial Results
07 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics Added to Russell 3000® Index
01 Jul 2024 07:00:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics Reports First Quarter 2024 Financial Results
09 May 2024 07:00:01 By Nasdaq GlobeNewswire
-
Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference
07 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
15 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
04 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
28 Mar 2024 16:30:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results
06 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics Announces $100 Million Private Placement
28 Feb 2024 08:05:00 By Nasdaq GlobeNewswire
-
28 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
04 Jan 2024 16:05:00 By Nasdaq GlobeNewswire
-
03 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics Reports Third Quarter 2023 Financial Results
09 Nov 2023 07:30:54 By Nasdaq GlobeNewswire
-
Applied Therapeutics to Present at the UBS Biopharma Conference 2023
02 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
01 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
28 Sep 2023 07:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >